will it really drop to $5? assuming 58m ebitda and using the same npat/ebitda (crude but just a back of envelope), underlying eps should be 39.26c, and i think it'll only go up from there. the real underlying npat might be less than H1 FY21 eps due to higher costs, but i think 40c is a reasonable assumption for next year. market looks to be pricing in negative growth.
- Forums
- ASX - By Stock
- KGN
- Ann: May 2021 Business Update
Ann: May 2021 Business Update, page-84
-
- There are more pages in this discussion • 74 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KGN (ASX) to my watchlist
|
|||||
Last
$4.45 |
Change
0.170(3.97%) |
Mkt cap ! $447.7M |
Open | High | Low | Value | Volume |
$4.28 | $4.56 | $4.21 | $4.209M | 945.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3999 | $4.44 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.49 | 2561 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3999 | 4.440 |
1 | 742 | 4.430 |
1 | 742 | 4.420 |
1 | 742 | 4.410 |
1 | 742 | 4.400 |
Price($) | Vol. | No. |
---|---|---|
4.530 | 3000 | 1 |
4.540 | 11777 | 4 |
4.550 | 15717 | 4 |
4.560 | 13048 | 2 |
4.570 | 1 | 1 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
KGN (ASX) Chart |